|
|
| 2022, Vol. 31(5): 425-430 DOI: 10.3760/cma.j.cn113030-20211117-00470 | ||
| Simultaneous integrated boost vs. routine IMRT in limited-stage small-cell lung cancer:an open-label,non-inferiority,randomized, phase 3 trial | ||
| Zhan Tianyou, Zhang Tao, Zhou Zongmei, Yan Wenbin, Zhai Yirui, Deng Lei, Wang Wenqing, Bi Nan, Wang Jianyang, Wang Xin, Liu Wenyang, Xiao Zefen, Feng Qinfu, Chen Dongfu, Lyu Jima, Hui Zhouguang, Liang Jun, Wang Lyuhua | ||
| Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China | ||
| Received 2021-11-17 Revised null | ||
| Supporting info | ||
| null | ||
|
